0001209191-23-038684.txt : 20230621 0001209191-23-038684.hdr.sgml : 20230620 20230620214549 ACCESSION NUMBER: 0001209191-23-038684 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morales Angel L CENTRAL INDEX KEY: 0001489738 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39289 FILM NUMBER: 231027297 MAIL ADDRESS: STREET 1: C/O CANO HEALTH, INC. STREET 2: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cano Health, Inc. CENTRAL INDEX KEY: 0001800682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 BUSINESS PHONE: 2034227700 MAIL ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 FORMER COMPANY: FORMER CONFORMED NAME: Jaws Acquisition Corp. DATE OF NAME CHANGE: 20200121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-15 0 0001800682 Cano Health, Inc. CANO 0001489738 Morales Angel L C/O CANO HEALTH INC. 9725 NW 117TH AVENUE MIAMI FL 33178 1 0 0 0 0 Class A Common Stock 2023-06-15 4 A 0 185598 A 248500 D These securities represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest on the earlier of (i) June 15, 2024 or (ii) the Issuer's next annual meeting of stockholders, in each case so long as the reporting person remains in service as a member of the board on such date. These RSUs have been awarded to the reporting person to fully satisfy the Issuer's 2023 total annual equity and cash compensation for non-employee directors. This amount includes RSUs received in lieu of the $50,000 cash portion of the reporting person's total annual compensation based on a price of $1.347 per share (based on the volume weighted average price of the Issuer stock over the twenty business days preceding the grant). /s/ David J. Armstrong, Attorney-in-Fact 2023-06-20